Literature DB >> 26195587

Bidirectional triggering association between migraine and restless legs syndrome: A diary study.

Ping-Kun Chen1, Jong-Ling Fuh2, Shuu-Jiun Wang3.   

Abstract

OBJECTIVE: Migraine is comorbid with restless legs syndrome (RLS). However, the temporal association between these two episodic disorders remains elusive. The current study investigated the temporal relationship between migraine and RLS attacks.
METHODS: Migraine patients with RLS were recruited from a headache clinic. Patients with symptomatic RLS, RLS mimics, daily headaches, or daily RLS attacks were excluded. The patients recorded their headaches and RLS attacks for two weeks in a diary. The severity of each headache or RLS attack was rated on a four-point (0-3) Likert scale. Logit-normal, random-effects models were employed to estimate the odds ratios (ORs) for the temporal association between migraine and RLS attacks.
RESULTS: Thirty migraine patients with RLS (28 F/2 M, mean age 35.5 ± 9.0 years) completed the study. On the basis of 420 daily diary records, migraine attacks were associated with subsequent RLS attacks occurring on the same and next nights (OR = 6.94, 95% confidence interval (CI) = 4.39-11.0 and OR = 3.00, CI = 1.92-4.68; both ITALIC! p < 0.001). RLS attacks were associated with subsequent migraine attacks only on Day 1 (OR = 1.97 (CI = 1.3-2.98; ITALIC! p = 0.01). Overall, the frequencies of migraine and RLS attacks in two weeks were correlated (Spearman's correlation = 0.56, ITALIC! p = 0.001).
CONCLUSIONS: Our study results showed a bidirectional triggering association between migraine and RLS attacks. The association was stronger and lasted longer for migraine triggering subsequent RLS than that for vice versa. © International Headache Society 2015.

Entities:  

Keywords:  Comorbidity; migraine; restless legs syndrome (RLS); temporal association

Mesh:

Year:  2015        PMID: 26195587     DOI: 10.1177/0333102415596444

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  7 in total

Review 1.  Sleep in Patients with Chronic Migraine.

Authors:  Chun-Pai Yang; Shuu-Jiun Wang
Journal:  Curr Pain Headache Rep       Date:  2017-09

Review 2.  The Comorbidity of Migraine and Restless Legs Syndrome.

Authors:  Semiha Kurt
Journal:  Curr Neurol Neurosci Rep       Date:  2019-07-27       Impact factor: 5.081

Review 3.  Non-headache symptoms in migraine patients.

Authors:  Ping-Kun Chen; Shuu-Jiun Wang
Journal:  F1000Res       Date:  2018-02-14

4.  The Prevalence of Restless Legs Syndrome in Patients with Migraine: A Systematic Review and Meta-Analysis.

Authors:  Hooman Ghasemi; Behnam Khaledi-Paveh; Alireza Abdi; Rostam Jalali; Nader Salari; Aliakbar Vaisi-Raygani; Masoud Mohammadi
Journal:  Pain Res Manag       Date:  2020-08-29       Impact factor: 3.037

5.  Genome-wide analysis identified novel susceptible genes of restless legs syndrome in migraineurs.

Authors:  Yun-Jin Jiang; Cathy Shen-Jang Fann; Shih-Pin Chen; Shuu-Jiun Wang; Jong-Ling Fuh; Ming-Yi Chung; Hui-Ying Huang; Kuo-Chang Chu; Yen-Feng Wang; Chia-Lin Hsu; Lung-Sen Kao
Journal:  J Headache Pain       Date:  2022-03-29       Impact factor: 7.277

Review 6.  Comorbidities of primary headache disorders: a literature review with meta-analysis.

Authors:  Valeria Caponnetto; Manuela Deodato; Paolo Martelletti; Alberto Raggi; Micaela Robotti; Maria Koutsokera; Valeria Pozzilli; Cristina Galati; Giovanna Nocera; Eleonora De Matteis; Gioacchino De Vanna; Emanuela Fellini; Gleni Halili; Daniele Martinelli; Gabriele Nalli; Serena Serratore; Irene Tramacere
Journal:  J Headache Pain       Date:  2021-07-14       Impact factor: 7.277

7.  Altered Brain Functional Connectome in Migraine with and without Restless Legs Syndrome: A Resting-State Functional MRI Study.

Authors:  Fu-Chi Yang; Kun-Hsien Chou; Ai-Ling Hsu; Jong-Ling Fuh; Jiing-Feng Lirng; Hung-Wen Kao; Ching-Po Lin; Shuu-Jiun Wang
Journal:  Front Neurol       Date:  2018-01-30       Impact factor: 4.003

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.